Upgrade to SI Premium - Free Trial

Vor Biopharma Inc. (VOR) Misses Q3 EPS by 2c

November 7, 2023 6:09 PM

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($0.49), $0.02 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

Categories

Earnings